To develop and validate a clinically applicable risk-prediction model for sepsis-induced cardiomyopathy (SICM) and to evaluate its predictive performance comprehensively.
Approach:
Study Design: A retrospective cohort study using clinical data from the MIMIC-IV database.
Data Analysis: Propensity score matching, univariate analysis, least absolute shrinkage and selection operator regression, and multivariate logistic regression were used.
Validation: The model was externally validated with an independent dataset of 104 patients.
Key Findings:
Five independent predictors were identified: serum phosphate concentration, neutrophil percentage, troponin concentration, heart rate, and Charlson Comorbidity Index from a cohort of 956 patients.
The model showed strong discriminatory ability with C-statistic values of 0.80 for the derivation cohort, 0.79 for the internal validation cohort, and 0.76 for the external validation cohort.
Interpretation:
The validated prediction model provides accurate estimation of SICM risk based on routinely available clinical variables.
Limitations:
The study is retrospective and may be subject to biases inherent in such designs.
The definition of SICM may not encompass all phenotypes of the condition.
Conclusion:
The model has potential utility for early risk stratification and individualized management of patients with sepsis.
Advanced heart failure and transplant cardiologist Sanjeev Kumar Gulati, M.D., FACC, has joined Baptist Health Heart & Vascular Care, and will serve as executive deputy director and system chief of cardiovascular medicine